Argentina and Global Clinical Trials Market Dynamics and Trends by 2028

Historic Data: 2020-2021 | Base Year: 2022 | Forecast Period: 2023-2028

Argentina and Global Clinical Trials Market Forecast to 2028 - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)

Report Date : Jul 2023
Report Code : TIPRE00034257

Category : Life Sciences
Status : Published

Available Report Formats :

Page Updated: Jan 2024

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

Analyst Perspective:

The clinical trials market in Argentina was valued at US$ XX million in 2022 and is projected to reach US$ XX million by 2028; it is expected to grow at a CAGR of 6.4% during the forecast period.

The Ministry of Health in Argentina (ANMAT) issued a new regulation that significantly reduces the timelines for the approval of clinical trials. The new regulation will expedite the evaluation process from 160 business days to 70 days or less. With this revised legislation, the number of clinical trials is expected to double in the country. Thus, with a favorable scenario for clinical trials in Argentina, the market for clinical trials is expected to grow during the forecast period.

The numerous key players in the clinical trials market in Argentina further boost the market growth. For instance, Activa Contract Research Organization in Argentina is a full-service CRO that offers various clinical development services for biotech, pharmaceutical, and medical device companies. It handles projects in all clinical phases of development and major therapeutic indications in oncology, hematology, cardiovascular, orphan diseases, CNS, and pivotal studies in medical devices.

Thus, developments in clinical trials and presence of key players in Argentina are driving the clinical trials market growth.

Market Segmentation - Clinical Trials Market

SEGMENT NAME	TYPE
Phase	Phase I, Phase II, Phase III, Phase IV
Study Design	Interventional, Observational, Expanded Access
Indication	Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others

Clinical Trials Market

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Key Player Analysis - Clinical Trials Market

IQVIA Holdings Inc
Parexel International Corp
IXICO Plc
Charles River Laboratories International Inc
ICON Plc
WuXi AppTec Co Ltd,
SGS SA
Syneos Health Inc
SIRO Clinpharm Pvt Ltd
Thermo Fisher Scientific Inc
Laboratory Corp of America Holdings

are the key Clinical Trials Market players profiled in the report.

Argentina and Global Clinical Trials Report Scope

Report Attribute	Details
Market size in 2022	US$ XX Million
Market Size by 2028	US$ XX Million
CAGR (2022 - 2028)	6.4%
Historical Data	2020-2021
Forecast period	2023-2028
Segments Covered	By Study Design Interventional Observational Expanded Access By Phase Phase I Phase II Phase III Phase IV By Indication Autoimmune/Inflammation Pain Management Oncology CNS Condition Diabetes Obesity Cardiovascular Disease
Regions and Countries Covered	Argentina Argentina
Market leaders and key company profiles	IQVIA Holdings Inc Parexel International Corp IXICO Plc Charles River Laboratories International Inc ICON Plc WuXi AppTec Co Ltd, SGS SA Syneos Health Inc SIRO Clinpharm Pvt Ltd

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Argentina and Global Clinical Trials Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy